|
15 La enfermedad pulmonar obstructiva crónica (EPOC) secundaria
a una injuria viral aguda grave tiene una prevalencia relativamente alta
en la Argentina con relación a otros países y genera un
fuerte impacto en la salud de los niños que la padecen. En nuestro
Hospital hay un programa interdisciplinario para la atención de
esta población. Al igual que en otros grupos de pacientes con
condiciones de salud crónicas y complejas, la evaluación
del crecimiento aplicada en forma individual es un indicador del estado
de salud general y una herramienta útil para monitorear el tratamiento;
aplicada a la población es un buen indicador de la calidad del
funcionamiento de un programa. Objetivo: evaluar el crecimiento de niños
con EPOC post viral. Pacientes y Métodos:
Chronic Lung Disease (CLD) secondary to a severe acute viral infection
has relatively higher prevalence in Argentina, and this situation has
a strong impact in the health condition of the affected children. As
in other groups of patients with chronic conditions, the evaluation of
physical growth is an excellent indicator of general health, treatment
follow-up. Moreover, when applied to these populations, the evaluation
of physical growth is an excellent indicator of the quality of the program.
Objective: to evaluate the growth of children with post-viral CLD. Patients
and Methods: Longitudinal and prospective growth of 100 children with
CLD between ages 0,05-2,83 years at the onset of the follow up was evaluated.
Anthropometric measurements were carried out in an standardized way every
3 months during the first year and every 6 months later on, for a period
varying between 1.00 to 4,70 years. Chi2 test was used to look for the
association between growth retardation and indicators of pulmonary function
severity. Results: according to growth in height, four types of curves
were identified: Type 1(n=45 children) with catch up growth at some time
during the follow up; type 2 (n=49) with complete normal growth; type
3 (n=5) with growth delay during the acute period followed by a normal
growth rate; and type 4 (n=1) with persistent growth delay after the
acute period of illness. We found a significant association between periods
of growth retardation and the need of 24 hours/day O2 therapy and PCO2
levels of more than 43 (p=0,027 and p= 0,029 respectively)
16 Introducción: La desnutrición infantil es un problema
vigente en Paraguay y en riesgo de aumentar en años recientes.
Introduction: Pediatric malnutrition is real problem in Paraguay and
in risk of increasing in recent years.
17 VALIDADE DE EQUAÇÕES PARA A ESTIMATIVA DA GORDURA CORPORAL
RELATIVA EM MODELOS ADOLESCENTES. Introdução: Normalmente utiliza-se a equação
de Slaughter et al. (1988) para a avaliação da composição
corporal de crianças e adolescentes, porém em grupos específicos
como o de modelos, que apresentam características físicas
bastante particulares, há a necessidade de se testar a validade
dessa equação, bem como de outras que possam ser utilizadas.
Objetivo: O objetivo deste estudo foi testar a validade de duas equações
antropométricas de estimativa da densidade corporal: Lewis et
al. (1978) e Slaughter et al. (1988), em um grupo de modelos profissionais
adolescentes do sexo feminino. Métodos: Foram avaliadas 11 modelos
(17,09 + 1,92 anos de idade), utilizando-se a pesagem hidrostática
(PH) como técnica padrão. As densidades obtidas pelas equações
foram convertidas em porcentagem de gordura (%G), utilizando-se a fórmula
de Siri (1961). As medidas de dobras cutâneas foram obtidas por
meio de um adipômetro da marca Sanny®, seguindo-se a padronização
descrita por Costa (2001). O critério de determinação
da validade adotado foi o proposto por Lohman (1992): correlação
linear de Pearson ( r ) > 0.80, Erro Padrão de Estimativa (EPE)
< 3,5 % de gordura corporal, e diferença não significante
no teste t de Student para amostras dependentes. Resultados:
Conclusão: A análise dos resultados demonstra que somente a equação proposta por Lewis et al. (1978) para avaliar atletas jovens do sexo feminino, atendeu a todos os critérios de validade no grupo estudado, permitindo-nos concluir que para modelos profissionais adolescentes, com características semelhantes, esta pode ser uma boa opção para a avaliação da composição corporal.
17 Introduction: It´s usually used Slaughter´s equation for
body composition assessment in children and adolescents, however in specific
groups as the one of top models, that presents particular physical characteristics,
it is necessary the cross-validation of this equation, as well as of
others that can be used. Objective: The purpose of this study was to
test the validity of two anthropometric equations for body density estimation:
Lewis et al. (1978) and Slaughter et al. (1988), in a professional top
models teenagers group. Methods: They were going evaluated 11 top models
(17,09 + 1,92 years old), using hydrostatic weighing (HW) as "gold
standard". The densities obtained by the equations were converted
in body fat percentage (BF), using the formula proposed by Siri (1961).
The skinfold thickness was obtained by Sanny® skinfold caliper, following
the standardizations proposed by Costa (2001). The criteria adopted to
determinate the validity of the equations was the proposed by Lohman
(1992): Pearson´s correlations coefficient ( r ) > 0.80, Standard
Error of Estimate (SEE) < 3,5 % of body fat, and non- significant
difference in paired t test.
Conclusion: The analysis of the results demonstrates that only the equations proposed by Lewis et al. (1978) to evaluate female young athletes, attended to all of the validity criteria in the studied group, so we conclude that for top models teenagers, with similar characteristics, this can be a good option to assess body composition.
18 CAMBIOS EN LOS NIVELES DE MINERALES Y PROTEINAS EN LECHE HUMANA SEGÚN
LA FRECUENCIA DE AMAMANTAMIENTO Existe escasa información sobre los cambios en la composición
de la leche humana durante el destete gradual, el que comienza alrededor
de los 6 meses, al incorporar los alimentos complementarios. La involución
de la glándula mamaria durante esta etapa afectaría a los
distintos nutrientes en diferente magnitud.
Se observó
un aumento significativo para la relación PS/CAS con menor número
de mamadas. Por el contrario, no hubo diferencias en los minerales analizados.
Los resultados obtenidos indican que la disminución en la frecuencia
de mamadas, que llevaría a una involución de la glándula
mamaria, afecta la proporción entre las proteínas lácteas
pero no modifica los niveles de los minerales estudiados. (Agradecemos
a las Autoridades del Hospital Distrital de Forres por su apoyo).
18 CHANGES IN MINERAL AND PROTEIN LEVELS IN HUMAN MILK ACCORDING TO
BREAST-FEEDING FREQUENCY There is little information about changes in human milk composition
during gradual weaning, which starts around the 6th month postpartum,
with the incorporation of complementary foods. The involution of the
mammary gland during this period would affect different nutrients in
diverse magnitude.
A significant increase in WP/CAS ratio was observed with a smaller number of feedings. However, there were no differences in mineral concentrations. These results indicate that the decrease in breast-feeding frequency, which would lead to an involution in the mammary gland, affects milk proteins proportion but does not modify the levels of the studied minerals. (We are grateful to the authorities of the Forres District Hospital for their support).
19 A assistência integral ao desenvolvimento da criança e
do adolescente deve permear as ações e práticas
do profissional de saúde. A presença de determinados comportamentos
na criança em desenvolvimento sugere a necessidade de investigação
psicológica. Buscar instrumentos que possam identificar crianças
com dificuldades adaptativas e indicá-las para tratamento é uma
determinação legal, política e ética. Objetivo:
Verificar a utilidade do CBCL como instrumento para triagem de crianças
com problemas de comportamento. Métodos: Três grupos de
crianças. G1:35(29,66%) crianças diagnosticadas com Transtorno
Autista(DSM-IV,1994) e expostas a escolarização na AMA(
idade média=7a 6m). G2:31(26,27%) crianças com Transtorno
de Linguagem (DSM-IV,1994) expostas a terapia fonoaudiológica
no Ambulatório de Distúrbios da Comunicação
Humana da UNIFESP(idade média=7a6m).G3:52( 44,06%) crianças
escolares sem problemas de linguagem ou de comportamento selecionadas
pela professoras e coordenadoras pedagógicas de duas escolas próximas à UNIFESP(idade
média=7a 7m).A escolaridade das mães variou da primeira
série de ensino fundamental ao ensino superior completo da seguinte
maneira: G1:9anos(ensino médio incompleto).G2:6anos(ensino fundamental
incompleto).G3: 9anos(ensino médio incompleto). O CBCL (Achenbach,1991)
traduzido e adaptado por Bordin (1995),foi aplicado nas 118 mães
das crianças em estudo, na forma de entrevista individual para
evitar a interferência da escolarização materna.Tal
questionário consta de 113 comportamentos atípicos que
a mãe deve avaliar como ausente, às vezes presente e frequentemente
presente, assinalando 0 ou 1 ou 2 respectivamente. A somatória
dos pontos obtidos é convertida em escore T, cuja nota de corte
em 60 separa os grupos clínicos e não clínicos.
Para análise estatística empregou-se a análise de
variância. Resultados: Os G1 e G2 tiveram T escores médios
significativamente maiores que o G3 (p=0,001). Os escores médios
de G2 foram maiores para a categoria agressivos e externalizadores (p=0,03).
O G1 obteve escore significantemente maior (p=0,0001) na categoria problemas
de pensamento e significativamente menor (p=0,01) na categoria ansiedade
que G2 e G3. O G3 teve T escore médio significativamente menor
nas categorias: isolamento, problemas sociais e problemas de atenção
(p=0,0001). O CBCL diferenciou os grupos de crianças com patologias
do grupo de escolares típicos,indicando ser uma ferramenta útil
para triagem de crianças com perfil clínico e não
clínico.
19 Introduction: The total assistance to children and adolescent development should follow the action and practice of health professionals. The presence of determined behaviors in children under development suggests the need of psychological investigation. Looking for instruments that could screen children with difficulties and indicate them for the treatment is a legal, political and ethical issue. Objective: Verify the CBCL usage as an instrument for screening children with behavior problems. Method: Three groups of children. G1:35 (29,66%) children with autistic disorder diagnostic (DSM-IV, 1994) and in a special school - AMA (average age = 7 years and 6 months). G2: 31 (26,27%) children with language disorders (DSM-IV, 1994) under speech therapy on the ADCH-UNIFESP (average age = 7 years and 6 months). G3: 52 (44,06%) school children without language or behavior disorders selected by teachers and pedagogical coordinators from two schools closed to UNIFESP (average age = 7 years and 7 months). The mothers academic knowledge varied from the first grade up to the completed university degree: G1: 9 years (uncompleted high school), G2: 6 years (uncompleted secondary school), G3: 9 years (uncompleted high school). CBCL (Achenbach, 1991) was translated and adapted by Bordin et al (1995), and it was used on 118 children's mothers in study, on individual interview basis to avoid the maternal academic/schooling interference. This inquiry is made of 113 non-typical behaviors, which the mother should evaluate as present (score 2), sometimes present (score 1) or never present (score 0). The total score is done through the addition of these points. The value of 60 divide the groups in clinical and non-clinical children. For the statistical analysis it was used the ANOVA. Results: G1 and G2 had meaningful medium scores higher than G3 (p= 0,001). The medium scores in G2 were higher on the category "aggressive behavior" and "externalizing"(p= 0,03). On G1 the category "thought problems" had a meaningful medium score higher than G2 e G3 (p= 0,0001) and the "anxious behavior" had a meaningful low medium score than G2 and G3 (p= 0,01). The G3 had Tmedium score lower on the following categories: "withdraw", "social problems" and "attention problems" (p= 0,0001). Conclusion: CBCL was able to differentiate the group of clinical children from the non-clinical typical school children. New researches should be done using CBCL to emphasize the importance of this instrument.
20 INTRODUCCION: La anemia por deficiencia de hierro (ADH) en la infancia
altera el desarrollo neurofuncional. En este contexto, hemos demostrado
que la transmisión de los estímulos sensoriales auditivos
ocurre más lentamente. Efectos de larga duración han sido
observados por medio de potenciales evocados auditivos de tronco cerebral
(PEA), al evaluar los parámetros habitualmente utilizados en la
práctica clínica, como latencia de las ondas e intervalos
interondas.
20 INTRODUCTION: Iron deficiency anemia (IDA) in infancy slows the developmental
progression of auditory pathway transmission. Long-lasting effects on
auditory brainstem responses (ABRs) have been demonstrated by assessing
parameters usually used in clinical practice such as waves latency and
inter-peak waves intervals, but not in amplitude.
21 Introducción: Campylobacter jejuni (Cj) es uno de los enteropatógenos bacterianos de más alta prevalencia en Chile y el mundo. La infección por Cj provoca un cuadro de gastroenteritis agudo luego de la ingestión de alimentos o agua contaminada. En países industrializados, esta situación es más frecuente en jóvenes adultos, por el contrario en países subdesarrollados la primoinfección ocurre tempranamente y los niños presentan altas tasas de infección. La campylobacteriosis es una zoonosis y entre los principales reservorios se destacan las aves de corral y de vida libre (cerdos, vacas, ovejas, perros y roedores). El contacto con Cj evoca en el huésped una fuerte respuesta inmune. En los países pobres, los lactantes poseen títulos elevados de IgG contra Cj lo que sugiere que no es infrecuente que éstos desarrollen infecciones subclínicas. Estudios realizados en lactantes chilenos mostraron una tasa de aislamiento de 10% de Cj en cuadros diarreicos y de 3.2% en niños asintomáticos. Objetivos: Estudiar la respuesta inmune para Cj en lactantes y niños chilenos en los que no se ha evidenciado sintomatología clínica. Materiales y métodos: Se evaluó la respuesta inmune para Cj en un total de 410 sueros La población estudiada incluyo cuatro grupos. Grupo 1 (n: 192) lactantes menores de 18 meses; Grupo 2 (n: 36) niños entre 2 y 8 años; Grupo 3 (n: 83) niños entre 9 y 13 años y Grupo 4 (n: 169) adultos donadores de sangre (edad promedio 30 años). Los niveles de IgG se determinaron mediante una ELISA desarrollada y estandarizada con antígenos de superficie de una cepa aislada localmente. El reconocimiento de epítopes de Cj se evaluó por Inmunoblot. Resultados: Se detectó anticuerpos IgG para Cj en 55 de 192 lactantes (29%). Los niños mayores (grupo 2 y 3) presentaron una tasa de infección alta, de 39 y 34% respectivamente. Por el contrario, en los adultos se observó un menor frecuencia de infección (18%, 30/169). Conclusión: La alta tasa de seropositividad a Cj en los niños chilenos sugiere que en nuestra población la infección se produce a corta edad y las tasas se mantienen elevadas en pre-escolares y niños mayores.
21 Introducción: Campylobacter jejuni Cj is an enteropathogen with a wide distribution in Chile and the world. Cj infection causes enteritis in humans after the ingestion of contaminated food or untreated water. Campylobacter infections in the developing world differs markedly from that in the developed areas. In industrialized countries, illness is more common in young adults while in poorer environments the highest incidence of infection is found in children. Campylobacteriosis is a zoonosis, being poultry and cattle the most frequent sources of human infection. Puppies, kittens, pigs, sheep, rodents, and wild birds may also serve as reservoirs. Cj Infection induces a strong IgG antibody response. Infants from less developed regions usually have high IgG levels againts Cj because the infection is acquired during the first years of life, but often remains sub clinical or minimally symptomatic. Studies in Chilean infants showed Cj isolation rates of 10% in children with diarrhoea and 3.2 % in non-symptomatic children. Objetives: To study the immune response to Cj in infants and children that did not present clinical symptoms. Materials and Methods: immune response against Cj was studied in sera from 410 individuals. The population studied included four groups. Group 1 (n: 192): infants less 18 months; Group 2 (n: 36): children between 2 and 8 yeas old; Group 3 (n: 83): children between 9 and 13 years old and Group 4 (n: 169): healthy adults blood donors (average 30 years old). The serum IgG levels against Cj was determined through an "in house" ELISA protocol previously standardized in our laboratory, using a surface antigen obtained from a local isolate as capturer. The reactivity of the sera against Cj epitopes was evaluated by Immunoblot. Results: IgG antybodies for Cj were detected in 55 of 192 infants (29%). Groups 2 and 3 showed a higher incidence of infection, 39 and 34% respectively. On the contrary, a lower rate of infection (18%, 30/169) was observed in adults. Conclusions: The high rate of seropositivity to Cj in children suggest that in our population the infection occurs early, and the infection frequency remains elevated in pre-school and older children.
22 Introducción: La preeclampsia severa es aún uno de los
mayores problemas obstétricos en países en vías
de desarrollo.
22 Background: Severe preeclampsia remains one of the major obstetrical
problem in developing countries
23 Introducción: En Neonatologia el uso de Indometacina (INDO) está ampliamente
difundido para el cierre del Ductus Arteríoso Persistente en prematuros
y la dosis habitual es 0,1 a 0,2 mg/kg.En Argentina la única forma
comercial de lNDO(IM 75®= 50mg/2m!) obliga a la reconstitución
del preparado luego de dos diluciones para alcanzar la dosis neonataI.En
la práctica clínica se ha sugerido que esta dilución
puede ser riesgosa e imprecisa,e incluso algunos neonatólogos
han optado por otra droga de igual eficacia, aunque menos estudiada.
No existen en la actualidad estudios publicados que demuestren si la
dilución de la lNDO modifica la dosificación teórica
indicada Objetivo:Evaluar si la dosis de indometacina (1M 75®) administrada
en una UClN es equivalente a la dosis teórica indicada Material
y método: Se seleccionaron aleatoriamente 50 enfermeras, quienes
desconocían el objetivo del estudio. A cada una de ellas se les
solicitó que realicen la dilución estándar de la
droga para una dosis estimada de 0.2 mg/kg en un neonato con peso teórico
de 1000 g. Se analizaron dos series de 50 muestras correspondientes a
las diluciones para la dosis teórica indicada: 0.5mg/ml y 0.2
mg/12ml. Cada muestra fue analizada por triplicado mediante cromatografia
liquida de alta performance y se consignó
como concentración real de INDO el promedio de las tres mediciones.
Se compararon las concentraciones obtenidas con respecto a las teoricas
(0.5mg/ml y 0.2 mg/12ml) mediante test t de Student. Resultados: la dilución
intermedia y final mostró diferencias significativas con la esperada
El 64 % (32/50) de las muestras de la dilución final superó en más del 20 % la concentración indicada de 0.2mg/12ml; en ningún caso se observaron mediciones por debajo del 20 % de la concentración teorica.Conclusiones: Luego de las diluciones, las dosis real de Indometacina (IM75®) no es equivalente a la indicada En la mayoria de los casos las dosis administradas superan ampliamente a la dosis teórica. Sería necesario analizar si estas diferencias se asocian a concentraciones plasmáticas tóxicas y/o mayores eventos adversos en los prematuros tratados con INDO en nuestro país.
23 INDOMETHACIN: DELIVERED DOSE VS ACTUAL DOSE Introduction: Indomethacin (INDO) is frequentely used for the pharmacological closing of ductus in premature babies, and the usual dose is 0,1 to 0,2 mg/kg. In Argentina Indomethacin is supplied as 2cc vials (IM 75 5O mg/ml) and have to be diluited twice to reach the neonatal dose .It has been suggested that this dilution could be risky,and many physicians have chosen another drugs with similar effectiveness, although less well studied.To our knowledge,at present, published studies demostrating that INDO dilution modifies the theoretical dose indicated doesn't exist. Objective: To assess if INDO (IM75) dose. administered in a NICU is equivalent to the theoretical indicated dose .Material and Methods: 50 nurses were selected by random sampling . They were blinding to the study objective.They have to prepare the standard solution of the drug for a hypothetical 1000grs newborn (0,2 mg/k) .They did two series of 50 samples corresponding to the following dilutions: 0.5 mg/k and 0.2 mg/12ml.Each sample was analyzed by triplicate by liquid chromatography of high performance.The average of the three values was recorded. We compared the concentration obtained with the theoretical one (0.5 mg/ml , 0.2 mg/12ml). Student's t test was used for analysis Results:there were significant differences between the actual and awaited dose, with regard to intermediate and final dilution
Sixty four percent (32/50) of the final dilution samples surpassed by more than 20% the indicated concentration (0,2mg/12ml). No sample had a value less than 20% the theoretical dose . Conclusions: after dilution, the actual dose of indomethacin (IM75) is not equivalent to the indicated one. In most cases, the administered doses surpassed widely the theoretical indicated. It would be necessary to analyze if these differences are associated with toxic plasmatic concentrations and/or higher frequency adverse effects in premature babies undergoing indomethacin treatment in Argentina. 24 La obesidad se asocia a dislipidemia, hipertensión, resistencia a la insulina e intolerancia a la glucosa y diabetes 2, agrupadas en el denominado síndrome metabólico, su agregación se considera potente factor de riesgo de enfermedad cardiovascular del adulto. El objetivo del presente trabajo fue estimar la prevalencia del agrupamiento de los componentes clásicos del síndrome metabólico en una población de niños y adolescentes obesos. Mat y métodos: Fueron incluidos 182 niños (99 m, 83 v) de edad media 11,1± 2,8 años, que consultaron por obesidad sin manifestaciones clínicas de otra patología. El síndrome metabólico fue definido como la asociación de resistencia insulínica o alteración del metabolismo hidrocarbonado sumado a otras 2 manifestaciones (OMS 1998. La obesidad fue evaluada por el IMC > 85 Plo (Rolland Cachera). A todos los pacientes se les realizó un test de tolerancia a la glucosa oral con dosajes de glucosa e insulina por RIA, dosaje de triglicéridos y colesterol y determinación de tensión arterial. Se definieron diabetes o intolerancia a la glucosa según criterios de ADA. La resistencia a la insulina fue evaluada por medio del modelo homeostático considerándose resistencia a un valor mayor a 1 DS de la media normal. La hipertensión arterial se definió como sistólica o diastólica mayores al plo 95 de las tablas dela Task Force. El análisis estadístico se realizó con Statistix 7. Las diferencias entre variables continuas se analizaron con test de student y test de chi cuadrado para variables categóricas. Se consideró significativa una p igual o menor a 0.05. Resultados: El síndrome metabólico estuvo presente en el 46,1 % de la población obesa. La frecuencia de las diferentes manifestaciones fue: resistencia a la insulina 65,3%, hipertensión 58.2%, hipertrigliceridemia 21,9% e intolerancia a la glucosa 8.8%. Se encontró una diferencia significativa en la magnitud de la obesidad entre el grupo con síndrome metabólico y sin este: IMC 32,9+-5,9 vs. 29,9 +- 5,3 ( p< 0,0005).No se encontraron diferencias en otras variables. La resistencia a la insulina fue la manifestación mas frecuente asociada a obesidad. Conclusiones: el agrupamiento de variables de riesgo cardiovascular denominado síndrome metabólico, basado en la definición de la OMS estuvo presente en 1 de cada 2 niños. La implicancia práctica es la necesidad de identificación temprana en función de objetivos preventivos.
24
25 Introdução: Carências nutricionais na infância se apresentam como importantes problemas de saúde pública em países em desenvolvimento. Além disso, crianças com carência de um micronutriente apresentam maior risco de apresentar, simultaneamente, carências de outros micronutrientes. Objetivos: Identificar a prevalência de carência de ferro no sangue periférico na população estudada, além de verificar se tal deficiência se apresenta como um fator de risco para a deficiência de vitamina A (DVA). Metodologia: Em um ambulatório de Pediatria Geral em Ribeirão Preto (SP/Brasil) foram selecionadas 188 crianças com idades ³ 24 meses e < 72 meses sem diarréia e/ou febre no momento da coleta. A identificação de DVA foi realizada através do +S30DR. Para a pesquisa da carência foi obtida amostra de sangue periférico em jejum para dosagem dos seguintes índices hematimétricos: níveis de hemoglobina, ferro sérico e da capacidade latente de fixação de ferro (UIBC). Foram consideradas com carência de ferro crianças com hemoglobina <11,0g/dl e/ou ferro sérico <50mg% e/ou relação ferro sérico:capacidade de ligação de ferro total (TIBC) <16% e/ou ainda UIBC >346mg/dl. Foi realizada inspeção ocular à procura de xeroftalmia, além das medidas de peso e altura para análise antropométrica do estado nutricional. Resultados: 39,9% (55/138) das crianças com DVA e 33,3% (16/48) sem DVA apresentaram carência de ferro. No total, 38,2% (71/186) das crianças apresentaram carência de ferro e 74,5% (140/188), DVA. A carência de ferro não se apresentou como um fator de risco para a DVA (p=0,42: teste do c2). Análise separada de cada índice hematimétrico também não mostrou diferença significativa entre as crianças com e sem DVA. Apenas 3,7% (7/188) das crianças apresentavam desnutrição. Nenhuma criança apresentou xeroftalmia. Conclusões: Apesar da carência de ferro não se apresentar como um fator de risco para a DVA, ambas as carências apresentaram prevalências elevadas em uma população "saudável" e com baixo índice de desnutrição; tal situação é conhecida como "fome oculta". Tais achados estimulam mais estudos para identificar grupos de risco para tais carências para se planejar ações para combatê-las.
25 Introduction: Childhood nutritional privation is an important health care problem in developing countries. In addition, children lacking a micronutrient present a higher risk of lacking other micronutrients at the same time. Objectives: Identifying the predominance of iron privation in peripherical blood of the population studied, as well as verifying if such privation is a risk factor for vitamin-A deficiency (DVA). Methodology: In preschool children at a General Pediatrics outpatient clinic in Ribeirão Preto (SP/Brasil), 188 children at ³ 24 months and < 72 months of age, with no diarrhea and/or fever at collection, were selected. DVA identification was carried out through +S30DR. As to the research on privation, a sample of peripherical blood from fasting children was obtained for dosage of the following hematimetric indexes: hemoglobin counts, seric iron, and unsaturated iron binding capacity (UIBC). Children presenting hemoglobin count <11,0g/dl and/or seric iron level <50mg% and/or seric iron:total iron binding capacity (TIBC) rate <16% and/or UIBC >346mg/dl were considered having iron deficiency. Ocular inspection for signs of xerophthalmia was performed on all children, in addition to weight and height measurements for anthropometric analysis of nutritional status. Results: 39,9% (55/138) children with DVA and 33,3% (16/48) without DVA have presented iron deficiency. 38,2% (71/186) children have presented iron deficiency and 74,5% (140/188), DVA. Iron deficiency has not been presented as a risk factor for DVA (p=0,42: c2 test). A separate analysis for each hematimetric index has also demonstrated no significant difference between children with or without DVA. Only 3,7% (7/188) children have presented malnutrition. No children have presented xerophthalmia. Conclusion: Although iron deficiency has not been presented as a risk factor for DVA, both deficiencies have been presented in high levels in "healthy" population with low malnutrition index; such situation is known as "hidden hunger". Such findings stimulate further studies for identifying risk populations as to such deficiencies in order to plan actions against them.
26 Antecedentes: Como una estrategia en el control de la deficiencia de
hierro, la fortificación de la harina de trigo está establecida
en muchos países, especialmente el Latinoamérica. En la
mayoría de los casos se usa hierro elemental reducido de pequeña
partícula debido al menor costo y bajo efecto de cambios organolépticos.
Sin embargo, su biodisponibilidad es cuestionable.
26 Background: As a strategy to eradicate iron deficiency, iron fortification
of wheat flour is extensively used worldwide. In most cases elemental
iron powders are utilized as fortificants due to their lower cost and
few, if any, sensory problems. However, their bioavailability is questionable.
27 Objetivo: Evaluar el estado nutricional antropométrico y el estado
nutricional de hierro, Vitamina B12 y Folato en pacientes con Síndrome
de Intestino Corto (SIC) luego de suspendida la Nutrición Parenteral
(NP) por no menos de 2 años. Pacientes y Métodos: Se estudiaron
10 pacientes pediátricos con SIC. Se evaluaron parámetros
antropométricos: peso, talla, perímetro braquial y espesor
de los pliegues cutáneos subescapular, suprailíaco, bicipital
y tricipital con caliper Lange. Se utilizó la clasificación
del estado nutricional de Waterloo según porcentajes de adecuación
de peso/talla (P/T) y talla/edad (T/E) usando tablas de referencia de
NCHS. Se dosaron los valores de hemoglobina y su volumen y concentración,
ferritina, transferrina, ferremia y la saturación porcentual de
transferrina, ácido fólico y vitamina B12. Se realizo una
encuesta alimentaria. Resultados: El rango de edad fue 3.3-12.9 años.
La media del intestino remanente fue 46.3 cm (rango:20-70), yeyuno: 30.4
(10-60), ileon 17.9 cm(0-60). El tiempo promedio de dependencia de NP
fue 378.5 días (rango:70 - 900). El P/T fue normal en 8 pacientes,
en 2 se encontró un déficit grado I, y bajo porcentaje
de masa grasa y magra en 1 de ellos. La T/E fue anormalmente baja en
5 pacientes: 3 de grado 1, y 2 de grado II. Los mismos ya tenían
afectada la talla durante el período de NP. El % de masa adiposa
fue bajo en 5 pacientes; 3 pacientes mostraron anemia, 2 de los cuales
presentaron macrocitosis. Esta alteración del VCM se encontró también
en 2 casos no anémicos. Se observaron niveles bajos de vitamina
B12 (1 paciente) y folatos séricos (4 pacientes). La encuesta
alimentaria mostró que el consumo promedio diario de vitamina
B12 y ácido fólico era adecuado y el 50% de los pacientes
no lograba la adecuación del consumo de hierro. La ingesta calórica
fue 110% (rango: 67-238) y proteica 326% (r:122-684). Conclusión:
La malabsorción leve y la malabsorción de micro nutrientes
puede manifestarse sutil y tardíamente. La talla de 50% de los
pacientes fue afectada desde el período en que recibieron NP y
a pesar de que el % de adecuación de ingesta proteica fue muy
superior al 100% en todos los pacientes, parecieran no tener capacidad
de crecimiento compensatorio en el periodo post NP. Los pacientes con
SIC deben recibir un riguroso control nutricional y un estrecho seguimiento
clínico biológico a largo plazo luego de suspendida la
NP.
27 AIM: To evaluate the anthropometric, iron, B12 Vitamin and folato nutritional condition in patients with short bowel syndrome (SBS) after suspending parenteral nutrition (PN) for no less than 2 years. PATIENTS AND METHODS: We studied 10 pediatric patients with SBS. The anthropometric parameters evaluated were weight, height, brachial perimeter, and width of subscapular, suprailiac, bicipital and tricipital cutaneous folds with Lange caliper. The Waterloo classification of nutritional condition was used according to weight/height (W/H) and height/age (H/A) fitting percentages with the NCHS reference tables. Hemoglobin values, volume and concentration were assessed, as well as those of ferritin, transferrin, ferremia and percent saturation of transferrin, folic acid and B12 vitamin. A nutritional survey was also performed. RESULTS: The age range of the patients was 3.3 - 12.9 yrs. The means of residual bowel was 46.3 cm (range:20-70), jejunum: 30.4 (10-60), ileum 17.9 cm (0-60). The average time of dependence of PN was 378.5 days (range:70 - 900). The W/H was normal in 8 patients, with a Score I deficit in 2 patients and a low percent of fatty and lean body mass in 1 patient. The H/A was abnormally low in 5 patients: 3 Score 1, and 2 Score II. Height was already affected during the PN period The percent of adipose mass was low in 5 patients. Three patients presented anemia, two of which also developed macrocytosis. Such alteration in MCV was also found in two cases where anemia was absent. The levels of B12 vitamin (1 patient) and serum folates (4 patients) were low. The nutritional survey showed that the average daily intake of B12 vitamin and folic acid was adequate, while 50% of patients could not adapt the intake of iron. The caloric and protein intake were 110 (range: 67-238) and 326 (r:122-684), respectively. CONCLUSION: Malabsorption of macro and micronutrients can manifest subtly and late. Height in 50% of patients was affected as of the period they were receiving PN. Despite the protein intake fitting percent was well above 100% in all patients, they would apparently not be able to develop a compensatory growth capacity in the post-PN period. Both nutritional control and long-term clinical-biological follow-up should be very strict in SBS patients once PN has been suspended. 28 Fundamentos: los recién nacidos (RN) de peso bajo reciben inicialmente
dextrosa por vía intravenosa (IV). El aporte contínuo de
soluciones glucosadas mediante gastroclisis (GC), podría ser una
alternativa con ventajas potenciales.
28 Early intravenous (IV) fluids are usually given to preterm infants to assure an adequate water and glucose balance. The continuous infusion of fluids through an orogastric (OG) tube may be an alternative with potential advantages such as easier, less painful and lower costs. Objective. To assess the efficacy and safety of a continuous OG infusion of glucose solutions in the initial fluid management of preterm infants with BW between 1000 and 1749 g. Design/ Methods. Multicenter randomized controlled trial. Primary outcome measure was need for IV access. Infants weighing 1000-1749 g at birth were considered for inclusion. Exclusion criteria were 5 minute Apgar score < 6, major congenital malformations, RDS requiring FiO2 > 0.6 and MAO > 8 in the first 2 hours, early hypoglycemia and severe clinical condition. Infants were randomized within the first 2 hours after birth to an OG or an IV group. The fluid solution (D10w) and the amount prescribed were the same for both groups. The intervention lasted until 100ml/k/d of enteral feedings were reached. Discontinuation of the OG infusion was considered if any of the following conditions were present: 1) Gastric residuals > 25% of previous 3 hours intake; 2) Symptomatic polycythemia; 3) Clinical deterioration as judged by the neonatologist; 4) NEC. Results. 62 infants were randomized to the OG group and 67 to the IV group. Forty percent of the infants in the OG group did not required an OG line. In the remaining 60%, fluid administration was switched to an IV route. No differences were found in polycythemia, hypoglycemia, hypernatremia time to reach reach 100ml/k/d of enteral feeds, maximum weight loss, sepsis and NEC. The major reasons for discontinuation of OG fluids were clinical deterioration and high residuals. A logistic regression analysis showed that suspected or proven sepsis (OR 12.9, 95% CI 2.4 - 68.5) and preeclampsia (OR 5.9, 95% CI 1.3 - 28.2) were independently associated with discontinuation of OG infusion. Conclusions. Early orogastric infusion of a glucose solution in stable preterm infants with BW 1000 - 1749 g resulted in a reduction of 40% in the use of IV lines, and was not associated with increased complications. Preeclampsia was associated with failure of successful early orogastric infusion. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||